mTOR Pharmaceutical Composition for Treating Macular Degeneration Containing mTOR Inhibitor

摘要

The present invention relates to a pharmaceutical composition for treating macular degeneration, and more particularly, to a pharmaceutical composition for treating macular degeneration containing an inhibitor which inhibits the expression of mTOR genes. Age-related macular degeneration, a typical retinal disease that causes adult blindness, can be effectively treated.